Monitoring aspirin therapy with the Platelet Function Analyzer-100.

about

Inconsistency of different methods for assessing ex vivo platelet function: relevance for the detection of aspirin resistance.

P2860

Q34371114-9D6FDD5B-7A5E-46CC-8D9C-D5366E156CC1

P2860

Monitoring aspirin therapy with the Platelet Function Analyzer-100.

Item

http://www.wikidata.org/entity/Q46465847

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Monitoring aspirin therapy with the Platelet Function Analyzer-100.

@en

Monitoring aspirin therapy with the Platelet Function Analyzer-100.

@nl

type

Item

label

Monitoring aspirin therapy with the Platelet Function Analyzer-100.

@en

Monitoring aspirin therapy with the Platelet Function Analyzer-100.

@nl

prefLabel

Monitoring aspirin therapy with the Platelet Function Analyzer-100.

@en

Monitoring aspirin therapy with the Platelet Function Analyzer-100.

@nl

P1476

Monitoring aspirin therapy with the Platelet Function Analyzer-100.

@en

P2093

Anne-Mette Hvas

http://www.w3.org/2001/XMLSchema#string

Helle Ladefoged Nielsen

http://www.w3.org/2001/XMLSchema#string

Jens Refsgaard

http://www.w3.org/2001/XMLSchema#string

Jette Mortensen

http://www.w3.org/2001/XMLSchema#string

Sofie Sommer Thygesen

http://www.w3.org/2001/XMLSchema#string

Susanne Bendesgaard Pedersen

http://www.w3.org/2001/XMLSchema#string

Tina Svenstrup Poulsen

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis

Statistical methods for assessing agreement between two methods of clinical measurement

In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor

A critical appraisal of the phenomenon of aspirin resistance

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100

PFA-100 and flow cytometry: can they challenge aggregometry to assess antiplatelet agents, other than GPIIbIIIa blockers, in coronary angioplasty?

Aspirin resistance

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

P304

786-792

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00365510802262680

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Erik L. Grove

Susanne Bendesgaard Pedersen

Steen Dalby Kristensen

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51424846

http://www.w3.org/2001/XMLSchema#string

P698

18651324

http://www.w3.org/2001/XMLSchema#string

P921

aspirin

Monitoring aspirin therapy with the Platelet Function Analyzer-100.

about

P2860

P2860

Monitoring aspirin therapy with the Platelet Function Analyzer-100.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921